Peter H. O'Donnell to Organoplatinum Compounds
This is a "connection" page, showing publications Peter H. O'Donnell has written about Organoplatinum Compounds.
Connection Strength
0.142
-
Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations. Pharmacogenomics J. 2013 Feb; 13(1):35-43.
Score: 0.099
-
Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy. J Clin Oncol. 2019 10 10; 37(29):2592-2600.
Score: 0.043